[1] Prince M, Wimo A, Guerchet M, et al. World Alzheimer Report 2015. The Global Impact of Dementia. An Analysis of Prevalence, Incidence, Cost and Trends. 2015. [2] Oddo S, Caccamo A, Shepherd JD, et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles:intracellular Abeta and synaptic dysfunction[J]. Neuron, 2003, 39(3):409-421. [3] Esfahani M, Movahedian A, Baranchi M, et al. Adiponectin:an adipokine with protective features against metabolic syndrome[J]. Iran J Basic Med Sci, 2015, 18(5):430-442. [4] Chan KH, Lam KS, Cheng OY, et al. Adiponectin is protective against oxidative stress induced cytotoxicity in amyloid-beta neurotoxicity[J]. PLoS One, 2012, 7(12):e52354. [5] Qiu G, Wan R, Hu J, et al. Adiponectin protects rat hippocampal neurons against excitotoxicity[J]. Age (Dordr), 2011, 33(2):155-165. [6] Pinskiy V, Tolpygo AS, Jones J, et al. A low-cost technique to cryo-protect and freeze rodent brains, precisely aligned to stereotaxic coordinates for whole-brain cryosectioning[J]. J Neurosci Methods, 2013, 218(2):206-213. [7] Iwama S, Sugimura Y, Murase T, et al. Central adiponectin functions to inhibit arginine vasopressin release in conscious rats[J]. J Neuroendocrinol, 2009, 21(9):753-759. [8] Liu J, Guo M, Zhang D, et al. Adiponectin is critical in determining susceptibility to depressive behaviors and has antidepressant-like activity[J]. Proc Natl Acad Sci U S A, 2012, 109(30):12248-12253. [9] Fedotova J, Soultanov V, Nikitina T, et al. Cognitive-enhancing activities of the polyprenol preparation Ropren(R) in gonadectomized beta-amyloid (25-35) rat model of Alzheimer's disease[J]. Physiol Behav, 2016, 157:55-62. [10] McClean PL, Holscher C. Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease. Neuropharmacology, 2014, 86:241-258. [11] Qi L, Ke L, Liu X, et al. Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3beta pathway in an amyloid beta protein induced alzheimer disease mouse model[J]. Eur J Pharmacol, 2016, 783:23-32. [12] Billings LM, Oddo S, Green KN, et al. Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron, 2005, 45(5):675-688. [13] Waragai M, Adame A, Trinh I, et al. Possible involvement of adiponectin, the anti-diabetes molecule, in the pathogenesis of Alzheimer's disease[J]. J Alzheimers Dis, 2016, 52(4):1453-1459. [14] Ma J, Zhang W, Wang HF, et al. Peripheral blood adipokines and insulin levels in patients with Alzheimer's Disease:A replication study and meta-analysis[J]. Curr Alzheimer Res, 2016, 13(3):223-233. [15] Cheng KK, Lam KS, Wang Y, et al. Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells[J]. Diabetes, 2007, 56(5):1387-1394. [16] Wan Z, Mah D, Simtchouk S,et al. Globular adiponectin induces a pro-inflammatory response in human astrocytic cells[J]. Biochem Biophys Res Commun, 2014, 446(1):37-42. [17] Liu J, Guo M, Zhang D, et al. Adiponectin is critical in determining susceptibility to depressive behaviors and has antidepressant-like activity[J]. Proc Natl Acad Sci U S A, 2012, 109(30):12248-12253. [18] Ali T, Yoon GH, Shah SA, et al. Osmotin attenuates amyloid beta-induced memory impairment, tau phosphorylation and neurodegeneration in the mouse hippocampus[J]. Sci Rep, 2015, 5:11708. |